Antiretroviral Drugs for Millions
Highly active antiretroviral therapies have markedly altered the illness course of approx 1.3 million people since these therapies became widely prescribed in 1997. However, approx 80% of individuals who are on treatment are residents of industrialized countries of the world, where fewer than 10% of the HIV-infected individuals make their home. In contrast, in December 2004, in sub-Saharan Africa, less than 300,000 individuals are taking antiretroviral treatment (ARV) in an HIV-infected population of approx 26 million. This is substantially less than 1 patient out of 50 who meet the “Western” criteria for treatment.
KeywordsMalaria Fluconazole Poss Tert Tenofovir
Unable to display preview. Download preview PDF.
- 2.Kityo Mutuluuza C, Walker S, Kaleebu P, et al. Short-term virologic response to a triple nucleoside/nucleotide analogue regimen in adults with HIV infection in Africa within the DART Trial. 12th Conference on Retroviruses and opportunistic Infections; Boston, MA; 2005.Google Scholar
- 6.Farmer P, Leandre F, Mukherjee JS, et al. Community-based approaches to HIV treatment in resource-poor settings. Lancet 2001: 322; 1087–1088.Google Scholar
- 9.The Voluntary HIV-1 Counseling and Testing Efficacy Study Group. Efficacy of voluntary HIV-1 counseling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomized trial. Lancet 2000; 356: 103–112.Google Scholar
- 11.http://www.who.int/3x5 accessed october 9, 2005.